Brad Stanfield: Why Cancer Doctors Stood and Applauded
B Brad Stanfield Video Summary · June 12, 2026 View Full Protocol → Key Takeaways Daraxonasib is a breakthrough drug targeting the RAS family of genes, including KRAS, which drives many cancers. In a trial, Daraxonasib doubled median survival time for metastatic pancreatic cancer patients compared to standard chemotherapy (13.2 months vs. 6.6 months). The…
